Attention-deficit/hyperactivity disorder (ADHD) is a common and impairing disorder affecting
children, adolescents, and adults. Several treatment strategies are available that can …

Background Attention deficit hyperactivity disorder (ADHD) is one of the most commonly
diagnosed and treated psychiatric disorders in childhood. Typically, children and …

Background Attention deficit hyperactivity disorder (ADHD) is a common
neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the …

Attention‐deficit hyperactivity disorder (ADHD) is a complex disorder that can affect
individuals across the lifespan. It is associated with substantial heterogeneity in terms of …

Background: Medication is an important element of therapeutic strategies for ADHD. While
medications for ADHD are generally well‐tolerated, there are common, although less …

Background Psychostimulant medication, most commonly the catecholamine agonist
methylphenidate, is the most effective treatment for attention-deficit/hyperactivity disorder …

Study question Is methylphenidate beneficial or harmful for the treatment of attention-
deficit/hyperactivity disorder (ADHD) in children and adolescents? Methods Electronic …

Abstract According to DSM-IV TR and ICD-10, a diagnosis of autism or Asperger Syndrome
precludes a diagnosis of attention-deficit/hyperactivity disorder (ADHD). However, despite …

Survivors of childhood cancer frequently experience cancer-related cognitive dysfunction,
commonly months to years after treatment for pediatric brain tumors, acute lymphoblastic …

Atomoxetine, a selective norepinephrine (NE) reuptake inhibitor, was approved for attention
deficit/hyperactivity disorder (ADHD) treatment in children, adolescents and adults. We …